sno is a member of the ski oncogene family and shares ski 's ability to transform avian fibroblasts and induce muscle differentiation. Ski and SnoN are transcription factors that form both homodimers and heterodimers. They recognize a specific DNA binding site (GTCTAGAC) through which they repress transcription. Efficient homodimerization of Ski, mediated by a bipartite C-terminal domain consisting of five tandem repeats (TR) and a leucine zipper (LZ), correlates with efficient DNA binding and cellular transformation. The present study assesses the role of SnoN homodimerization and SnoN:Ski heterodimerization in the activities of these proteins. Unlike Ski, efficient homodimerization by SnoN is shown to require an upstream region of the protein in addition to the TR/LZ domain. Deletion of the TR/LZ from SnoN decreases its activity in transcriptional repression and cellular transformation. When co-expressed in vitro, c-Ski and SnoN preferentially form heterodimers. In vivo, they form heterodimers that bind the GTCTAGAC element. Tethered Ski:Sno hetero-dimers that lack TR/LZ domains are more active than either their monomeric counterparts, tethered Ski:Ski homodimers or full-length SnoN and c-Ski. This work demonstrates, for the first time, the differences between dimer formation by Ski and SnoN and underscores the importance of dimerization in their activity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC148280 | PMC |
http://dx.doi.org/10.1093/nar/27.4.1006 | DOI Listing |
Front Pharmacol
May 2024
Departments of Drug Discovery and Biomedical Sciences, Charleston, SC, United States.
Effective therapy for liver fibrosis is lacking. Here, we examined whether LP340, the lead candidate of a new-generation of hydrazide-based HDAC1,2,3 inhibitors (HDACi), decreases liver fibrosis. Liver fibrosis was induced by CCl treatment and bile duct ligation (BDL) in mice.
View Article and Find Full Text PDFBiomol Biomed
November 2023
Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
The ski-related novel gene (SnoN), encoded by the SKIL gene, has been shown to negatively regulated transforming growth factor-β1 (TGF-β1) signaling pathway. However, the roles of SnoN in hepatic stellate cell (HSC) activation and hepatic fibrosis (HF) are still unclear. To evaluate the role of SnoN in HF, we combined bulk RNA sequencing analysis and single-cell RNA sequencing analysis to analyse patients with HF.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
July 2022
Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
By establishing a rat diabetes model in rats with intervening treatment by Jiangtang Tongmai Prescription (JTTMP), this study explored the restorative pairing effect of JTTMP on diabetic lung injury. The model of type II diabetes model was used to establish the rat diabetes model, using a high-fat diet and streptozotocin (STZ) induction. Different doses of JTTMP and metformin were administered as a therapeutic to intervene, and blood was collected to assess the blood glucose level of each group of rats.
View Article and Find Full Text PDFMol Cell Proteomics
March 2022
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France. Electronic address:
RNF111/Arkadia is an E3 ubiquitin ligase that activates the transforming growth factor-β (TGF-β) pathway by degrading transcriptional repressors SKIL/SnoN and SKI. Truncations of the RING C-terminal domain of RNF111 that abolish its E3 function and subsequently activate TGF-β signaling are observed in some cancers. In the present study, we sought to perform a comprehensive analysis of RNF111 endogenous substrates upon TGF-β signaling activation using an integrative proteomic approach.
View Article and Find Full Text PDFExp Ther Med
November 2021
Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China.
Ski-related novel protein N (SnoN) negatively regulates the transforming growth factor-β1 (TGF-β1)/Smads signaling pathway and is present at a low level during diabetic nephropathy (DN), but its underlying regulatory mechanism is currently unknown. The present study aimed to assess the effects of insulin-controlled blood glucose on renal SnoN expression and fibrosis in rats with diabetes mellitus (DM). Streptozotocin-induced DM rats were treated with insulin glargine (INS group) following successful model establishment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!